Received Jul 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | — |
Shingrix Third dose given; This non-serious case was reported by a physician via call center representative and described the occurrence of extra dose administered in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on an unknown date) and Shingrix (received second dose of Shingrix on an unknown date). On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Shingrix Third dose given). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 09-JUL-2025 The healthcare professional mentioned that a patient received two doses of Shingrix and the by mistake a third dose was administered which led to extra dose administered. No further details were provided.